Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Revenue rises but margins narrow for Avingtrans
(Sharecast News) - Avingtrans reported a 30.4% increase in first-half revenue in its interim results on Wednesday, to £65.2m, compared to £50.0m in the same period last year. The AIM-traded firm said that despite the growth, its gross margin experienced a slight reduction to 31.6% for the six months ended 30 November, from 32.6%, primarily due to changes in the mix between OEM and aftermarket sales.
Adjusted EBITDA rose 14.1% to £7.3m, attributable to higher revenues.
However, the adjusted EBITDA margin decreased to 11.2% from 12.8%, mainly driven by increased OEM sales and augmented investment in the medical division.
Adjusted profit before tax reached £4.4m, up from £4.0m in the prior year's first half, with adjusted diluted earnings per share from continuing operations rising to 11.7p from 9.8p.
Additionally, the company reported a cash outflow from operating activities of £3.6m, swinging from a £4.1m inflow a year earlier.
Net debt stood at £2.2m at the end of November, primarily due to various investments and ongoing supply chain disruptions.
Operationally, the advanced engineering systems division saw a 31.3% revenue increase to £63.7m, accompanied by a 20% rise in EBITDA to £8.5m.
After the period ended, the division saw the merger of EPM and PSRE, forming a new AES division under the leadership of Austen Adams.
Additionally, the acquisition of S&P's assets for £4.1m in August last year, and the successful integration of HES and Hevac into Ormandy Bradford, were noted as milestones.
The division secured significant contracts, including two nuclear decommissioning contracts worth £14.5m for Metalcraft, and defence contracts totalling £5.5m for HT Luton.
In the medical and industrial imaging division, revenue remained steady at £1.5m, with developments in MRI and x-ray products pending volume build-up.
Despite that, the division reported an increased EBITDA loss of £0.6m, widening from £0.2m a year earlier, which was put down to ongoing development projects.
The division's acquisition of Adaptix for £7.2m and Magnetica's appointment of Televere Systems as its first US distributor marked significant strategic moves.
Positive market response was reported at the RSNA imaging conference, showcasing demand for the division's products.
Adaptix also started sales of vet products in the UK and USA, with volumes expected to increase in the next fiscal year.
"Despite some continuing supply chain instability and inflationary pressures, our tried-and-tested pinpoint-invest-exit (PIE) approach produced strong results during the period, as evidenced by increased revenue and stable gross margins, resulting in a double-digit percentage growth in adjusted EBITDA," said chairman Roger McDowell.
"The group has restructured itself, with the mature engineering business now all in one advanced engineering systems (AES) division.
"We continue to invest in AES and also in the medical and industrial imaging (MII) division."
McDowell said the company was now deliberately structured for future exits that should maximise shareholder value.
"The marketing of the 3D x-ray systems at Adaptix and the development of MRI systems at Magnetica are proceeding to plan to hit key milestones in 2024.
"The first half results again demonstrate that we are proactively managing continuing progress in the AES division.
"Our value creation goals are on track, supported by a conservative approach to debt, which the board deem to be prudent at this time."
At 1243 GMT, shares in Avingtrans were up 4.59% at 360.84p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.